Universitätsklinikum Mannheim

Re-Irradiation for Patients with Head and Neck Squamous Cell Carcinoma - A multicenter Analysis of 253 Patients of the jDEGRO Trial Group (2021) Roesch J, Oertel M, Dobiasch S, Fabian A, Fleischmann D, Von Der Gruen J, Hering D, et al. Conference contribution Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Final results of the CAO/ARO/AIO-12 randomized phase 2 trial (2021) Fokas E, Schlenska-Lange A, Polat B, Klautke G, Grabenbauer G, Fietkau R, Kuhnt T, et al. Conference contribution Krt20, krt5, esr1 and erbb2 expression can predict pathologic outcome in patients undergoing neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer (2021) Jütte H, Reike M, Wirtz RM, Kriegmair M, Erben P, Tully K, Weyerer V, et al. Journal article Visualization of the epimysium and fascia thoracolumbalis at the lumbar spine using MRI (2021) Adamietz B, Schoenberg SO, Reiser M, Uder M, Frank A, Strecker R, Weiss C, Heiß R Journal article Digital communication strategies in gastroenterology: Position paper of the LebensBlicke Foundation Digitale Kommunikationsstrategien in der Gastroenterologie (2021) Riemann JF, Teufel A, Ganslandt T, Hann A, Hildebrandt H, Jütte H, Meining A, et al. Journal article BACH1 and HIF1 alpha predict response to neoadjuvant nab-paclitaxel (nP) treatment in early breast cancer (BC) (2021) Vladimirova V, Schneeweiss A, Jackisch C, Weber KE, Denkert C, Schmatloch S, Karn T, et al. Conference contribution Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): Analysis of the GeparSixto randomized clinical trial (2021) Llop-Guevara A, Vladimirova V, Schneeweiss A, Villacampa G, Karn T, Zahm DM, Herencia-Ropero A, et al. Journal article, Original article Immune-related gene expression predicts response to neoadjuvant chemotherapy but not additional benefit from pd-l1 inhibition in women with early triple-negative breast cancer (2021) Sinn BV, Loibl S, Hanusch CA, Zahm DM, Sinn HP, Untch M, Weber K, et al. Journal article Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors – An analysis of 2765 patients from neoadjuvant clinical trials (2021) Villegas SL, Nekljudova V, Pfarr N, Engel J, Untch M, Schrodi S, Holms F, et al. Journal article Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition (2021) Knispel S, Gassenmaier M, Menzies AM, Loquai C, Johnson DB, Franklin C, Gutzmer R, et al. Journal article